Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to evaluate the utility of the QLQ-GINET21 in making clinical and therapeutic decisions.

Official Title
-----------------
A Study Evaluating The Clinical Utility Of The Health-Related Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours QUALINETS Study

Conditions
-----------------
Gastrointestinal Neuroendocrine Tumours

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patient with a diagnosis of gastrointestinal endocrine tumour. Patient able to read and understand the study questionnaires. Patient who has given informed consent in writing to take part in the study. Exclusion Criteria: Patient who is taking part in another clinical study during the study. Patients with another serious malignancy. Patients unable to meet the requirements of the protocol (non-compliant patients or those unfit to answer the questionnaires).

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Survey on the clinical utility of the QLQ-GINET21, which the investigator is to complete for each patient enrolled |  | Day 1 | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Socio-demographic variables of the investigator | Descriptive analysis of socio-demographic variables including age, gender, years of experience in treating neuroendocrine tumours (NETs), area of professional activity, capacity of the hospital | Day 1 | 
| Socio-demographic variables of the patient | Descriptive analysis of socio-demographic variables including age, gender, employment status, marital status, educational level | Day 1 | 
| Patients' health-related quality of life concerning gastrointestinal neuroendocrine using QLQ-GINET21 |  | Day 1 | 
| Patients' health-related quality of life concerning gastrointestinal neuroendocrine using QLQ-C30 |  | Day 1 | 
| Clinical characteristics of patients - time since first therapeutic intervention |  | Day 1 | 
| Health status as perceived by the patient | Patients assess their overall health status in relation to their gastrointestinal neuroendocrine tumour, with a question designed for this purpose: Please answer the question by marking the response that best defines your current health status as related to your neuroendocrine disease. The response options are: Very good, quite good, somewhat good, neither good nor bad, somewhat bad, quite bad, very bad. | Day 1 | 
| Clinical assessment of patient's health status by the investigator | The investigator evaluates the patient's health status in relation to the gastrointestinal neuroendocrine tumour by answering the following question: Overall, how would you rate the patient's health status in relation to their gastrointestinal neuroendocrine tumour as of today? The response options are: Very good, quite good, somewhat good, neither good nor bad, somewhat bad, quite bad, very bad. | Day 1 |